Volume 5, issue 1, December 2018

9 articles in this issue

Gene correction of HBB mutations in CD34⁺ hematopoietic stem cells using Cas9 mRNA and ssODN donors

Authors (first, second and last of 11)
- Justin S. Antony
- Ngadhnjim Latifi
- Michael S. D. Kormann
- Content type: Short Communication
- Open Access
- Published: 14 November 2018
- Article: 9
Chemotherapy and the pediatric brain

Authors
- Chrysanthy Ikonomidou
- Content type: Mini review
- Open Access
- Published: 06 November 2018
- Article: 8
The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases

Authors
- Dirk Holzinger
- Dirk Foell
- Christoph Kessel
- Content type: Mini review
- Open Access
- Published: 25 September 2018
- Article: 7
Precision medicine in pediatric oncology

Authors (first, second and last of 4)
- Stefan E. G. Burdach
- Mike-Andrew Westhoff
- Klaus-Michael Debatin
- Content type: Review
- Open Access
- Published: 31 August 2018
- Article: 6
Anti-inflammatory monocytes—interplay of innate and adaptive immunity

Authors
- Georg Varga
- Dirk Foell
- Content type: Mini review
- Open Access
- Published: 03 April 2018
- Article: 5
Intrauterine growth restriction - impact on cardiovascular diseases later in life

Authors
- Carlos Menendez-Castro
- Wolfgang Rascher
- Andrea Hartner
- Content type: Mini review
- Open Access
- Published: 20 March 2018
- Article: 4
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases

Authors (first, second and last of 7)
- Kelly M. Martinovich
- Nicole C. Shaw
- Stephen M. Stick
- Content type: Review
- Open Access
- Published: 06 February 2018
- Article: 3
CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility

Authors (first, second and last of 9)
- Julia Seyfarth
- Heinz Ahlert
- Marc Jacobsen
- Content type: Research
- Open Access
- Published: 06 February 2018
- Article: 2
Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis

Authors (first, second and last of 6)
- Teresa Schleker
- Eva-Maria Jacobsen
- Carsten Posovszky
- Content type: Research
- Open Access
- Published: 19 January 2018
- Article: 1

Volume 5, issue 1, December 2018

Gene correction of HBB mutations in CD34⁺ hematopoietic stem cells using Cas9 mRNA and ssODN donors

Chemotherapy and the pediatric brain

The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases

Precision medicine in pediatric oncology

Anti-inflammatory monocytes—interplay of innate and adaptive immunity

Intrauterine growth restriction - impact on cardiovascular diseases later in life

The potential of antisense oligonucleotide therapies for inherited childhood lung diseases

CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility

Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis

For authors

Explore

Navigation

Volume 5, issue 1, December 2018

Authors (first, second and last of 11)

Authors

Authors

Authors (first, second and last of 4)

Authors

Authors

Authors (first, second and last of 7)

Authors (first, second and last of 9)

Authors (first, second and last of 6)

For authors

Explore

Search

Navigation